TY - JOUR
T1 - A theranostic nanocomposite with integrated black phosphorus nanosheet, Fe3O4@MnO2-doped upconversion nanoparticles and chlorin for simultaneous multimodal imaging, highly efficient photodynamic and photothermal therapy
AU - Zhang, Qicheng
AU - Wang, Wentao
AU - Zhang, Ming
AU - Wu, Fan
AU - Zheng, Tao
AU - Sheng, Bulei
AU - Liu, Yihan
AU - Shen, Jian
AU - Zhou, Ninglin
AU - Sun, Yi
PY - 2020
Y1 - 2020
N2 - As a novel photosensitizer for photodynamic therapy (PDT), black phosphorus (BP) has attracted increasing attention recently. However, some of its inherent drawbacks hinder its further biomedical applications. As with most conventional photosensitizers, the PDT efficiency of BP is severely limited by the hypoxia tumor microenvironment and low tissue penetration of ultraviolet/visible light. Moreover, BP also faces additional problems, such as mismatch wavelength between photothermal therapy (PTT) and PDT, as well as no imaging ability for cancer diagnosis. Herein, we addressed these challenges through the combination of Fe3O4@MnO2-doped upconversion nanoparticles (UCNPs) and black phosphorus nanosheets (BPNs). By applying polyacrylic acid (PAA) as a chemical crosslinker, polylysine (PL) modified black phosphorus nanosheets were integrated with magnetic Fe3O4@MnO2-doped NaYF4:Yb/Er/Nd upconversion nanoparticles (MUCNPs) which could convert near-infrared (NIR) light into visible light. Then, a biocompatible photosensitizer, chlorin e6 (Ce6) was attached onto the obtained MUCNPs@BPNs to prepare MUCNPs@BPNs-Ce6 nanocomposites. BPNs and Ce6 were exploited to activate PTT and PDT under a single irradiation light of 808 nm with strong tissue penetration ability. Meanwhile, the doped Fe3O4 and MnO2 nanoparticles could provide T1 and T2 magnetic resonance (MR) imaging, which could form a multimodal imaging system with fluorescence imaging of Ce6. In addition, MnO2 could decompose overexpressed H2O2 in tumor microenvironment to generate O2 to enhance PDT. The magnetic BPNs-based nanocomposites provided multimodal imaging (including MR, fluorescence, optoacoustic, ultrasonic imaging) and displayed dramatically enhanced ability for tumor cell death with visualized synergistic phototherapy, which greatly facilitated the application of BPNs in biomedicine.
AB - As a novel photosensitizer for photodynamic therapy (PDT), black phosphorus (BP) has attracted increasing attention recently. However, some of its inherent drawbacks hinder its further biomedical applications. As with most conventional photosensitizers, the PDT efficiency of BP is severely limited by the hypoxia tumor microenvironment and low tissue penetration of ultraviolet/visible light. Moreover, BP also faces additional problems, such as mismatch wavelength between photothermal therapy (PTT) and PDT, as well as no imaging ability for cancer diagnosis. Herein, we addressed these challenges through the combination of Fe3O4@MnO2-doped upconversion nanoparticles (UCNPs) and black phosphorus nanosheets (BPNs). By applying polyacrylic acid (PAA) as a chemical crosslinker, polylysine (PL) modified black phosphorus nanosheets were integrated with magnetic Fe3O4@MnO2-doped NaYF4:Yb/Er/Nd upconversion nanoparticles (MUCNPs) which could convert near-infrared (NIR) light into visible light. Then, a biocompatible photosensitizer, chlorin e6 (Ce6) was attached onto the obtained MUCNPs@BPNs to prepare MUCNPs@BPNs-Ce6 nanocomposites. BPNs and Ce6 were exploited to activate PTT and PDT under a single irradiation light of 808 nm with strong tissue penetration ability. Meanwhile, the doped Fe3O4 and MnO2 nanoparticles could provide T1 and T2 magnetic resonance (MR) imaging, which could form a multimodal imaging system with fluorescence imaging of Ce6. In addition, MnO2 could decompose overexpressed H2O2 in tumor microenvironment to generate O2 to enhance PDT. The magnetic BPNs-based nanocomposites provided multimodal imaging (including MR, fluorescence, optoacoustic, ultrasonic imaging) and displayed dramatically enhanced ability for tumor cell death with visualized synergistic phototherapy, which greatly facilitated the application of BPNs in biomedicine.
KW - Photodynamic therapy
KW - Black phosphorus
KW - Photothermal therapy
KW - Multimodal imaging
KW - Synergistic phototherapy
U2 - 10.1016/j.cej.2019.123525
DO - 10.1016/j.cej.2019.123525
M3 - Journal article
SN - 1369-703X
VL - 391
JO - Chemical Engineering Journal
JF - Chemical Engineering Journal
M1 - 123525
ER -